These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24588205)

  • 1. Dawning of the epigenetic era in hereditary cancer.
    Hitchins MP; Lynch HT
    Clin Genet; 2014 May; 85(5):413-6. PubMed ID: 24588205
    [No Abstract]   [Full Text] [Related]  

  • 2. Epigenetic mechanisms in the pathogenesis of Lynch syndrome.
    Peltomäki P
    Clin Genet; 2014 May; 85(5):403-12. PubMed ID: 24443998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BMPR1A mutations in hereditary nonpolyposis colorectal cancer without mismatch repair deficiency.
    Nieminen TT; Abdel-Rahman WM; Ristimäki A; Lappalainen M; Lahermo P; Mecklin JP; Järvinen HJ; Peltomäki P
    Gastroenterology; 2011 Jul; 141(1):e23-6. PubMed ID: 21640116
    [No Abstract]   [Full Text] [Related]  

  • 4. Cumulative incidence of metachronous colorectal cancer risk for mismatch repair gene mutation carriers is overestimated.
    Renehan AG
    Gut; 2012 May; 61(5):783; author reply 783-4. PubMed ID: 21873468
    [No Abstract]   [Full Text] [Related]  

  • 5. Milestones of Lynch syndrome: 1895-2015.
    Lynch HT; Snyder CL; Shaw TG; Heinen CD; Hitchins MP
    Nat Rev Cancer; 2015 Mar; 15(3):181-94. PubMed ID: 25673086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lynch syndrome in patients with colorectal cancer: finding the needle in the haystack.
    Ladabaum U; Ford JM
    JAMA; 2012 Oct; 308(15):1581-3. PubMed ID: 23073955
    [No Abstract]   [Full Text] [Related]  

  • 7. Microsatellite instability and mismatch repair genes in colorectal cancer: useful tools for managing patients and counseling their relatives.
    Douillard JY
    Clin Colorectal Cancer; 2010 Oct; 9(4):193-4. PubMed ID: 20920989
    [No Abstract]   [Full Text] [Related]  

  • 8. Toward a consensus in molecular diagnosis of hereditary nonpolyposis colorectal cancer (Lynch syndrome).
    Lynch HT; Lynch JF; Lynch PM
    J Natl Cancer Inst; 2007 Feb; 99(4):261-3. PubMed ID: 17312298
    [No Abstract]   [Full Text] [Related]  

  • 9. Hereditary non-polyposis colorectal cancer/Lynch syndrome in three dimensions.
    Kravochuck SE; Church JM
    ANZ J Surg; 2017 Dec; 87(12):1006-1010. PubMed ID: 26990828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA mismatch repair in prostate cancer.
    Beltran H
    J Clin Oncol; 2013 May; 31(14):1782-4. PubMed ID: 23530097
    [No Abstract]   [Full Text] [Related]  

  • 11. Origin of MLH1, MSH2, MSH6 and PMS2 mutations can help inform long-term care strategies for patients with colorectal and endometrial cancer.
    Hickmott JW
    Clin Genet; 2015 Jun; 87(6):534-5. PubMed ID: 25761822
    [No Abstract]   [Full Text] [Related]  

  • 12. Is prostate cancer a Lynch syndrome cancer?
    Win AK
    Asian J Androl; 2013 Sep; 15(5):588-9. PubMed ID: 23817498
    [No Abstract]   [Full Text] [Related]  

  • 13. Detection of DNA repair protein in colorectal cancer of patients up to 50 years old can increase the identification of Lynch syndrome?
    Germini DE; Mader AM; Gomes LG; Teodoro TR; Franco MI; Waisberg J
    Tumour Biol; 2016 Feb; 37(2):2757-64. PubMed ID: 26408182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lynch syndrome in colorectal cancer patients.
    Giráldez MD; Castellví-Bel S; Balaguer F; Gonzalo V; Ocaña T; Castells A
    Expert Rev Anticancer Ther; 2008 Apr; 8(4):573-83. PubMed ID: 18402524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a new, simple and cost-effective diagnostic tool for genetic screening of hereditary colorectal cancer--the DNA microarray assay.
    Stojcev Z; Banasiewicz T; Kaszuba M; Sikorski A; Szczepkowski M; Bobkiewicz A; Paszkowski J; Krokowicz Ł; Biczysko M; Szmeja J; Jurkowska M; Majewski P; Mackiewicz A; Lamperska K; Drews M; Wojciechowicz J
    Acta Biochim Pol; 2013; 60(2):195-8. PubMed ID: 23741719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Selection criteria for search for germ mutations in colorectal cancer hereditary nonpolyposis].
    Ríos A; Rodríguez JM; Carbonel P; Parrilla P
    Med Clin (Barc); 2015 Feb; 144(4):185-6. PubMed ID: 25458510
    [No Abstract]   [Full Text] [Related]  

  • 17. Truncation of the MSH2 C-terminal 60 amino acids disrupts effective DNA mismatch repair and is causative for Lynch syndrome.
    Wielders E; Delzenne-Goette E; Dekker R; van der Valk M; Te Riele H
    Fam Cancer; 2017 Apr; 16(2):221-229. PubMed ID: 27873144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RE: Aspirin, Ibuprofen, and the Risk for Colorectal Cancer in Lynch Syndrome.
    Tuccori M; Filion KB; Azoulay L
    J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26711870
    [No Abstract]   [Full Text] [Related]  

  • 19. Heredity and DNA methylation in colorectal cancer.
    Jass JR
    Gut; 2007 Jan; 56(1):154-5. PubMed ID: 17172593
    [No Abstract]   [Full Text] [Related]  

  • 20. Constitutional mismatch repair-deficiency syndrome.
    Wimmer K; Kratz CP
    Haematologica; 2010 May; 95(5):699-701. PubMed ID: 20442441
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.